Literature DB >> 22113150

Exploring soluble urokinase plasminogen activator receptor and its relationship with arterial stiffness in a bi-ethnic population: the SAfrEIC-study.

Aletta E Schutte1, Anélda Myburgh, Michael H Olsen, Jesper Eugen-Olsen, Rudolph Schutte.   

Abstract

INTRODUCTION: Elevated soluble urokinase-type plasminogen activator receptor (suPAR) indicates an inflammatory state caused by conditions such as HIV and cancer. Recently suPAR was identified as an indicator of cardiovascular disease (CVD). CVD is highly prevalent in black South Africans, but the potential role of suPAR is unknown. We investigated suPAR as a possible marker of arterial stiffness in Africans and Caucasians.
METHODS: This study involved 207 Africans and 314 Caucasians (aged 20-70 yrs). C-reactive protein (CRP) and suPAR were determined in fasting blood samples. We measured blood pressure, pulse wave velocity (PWV) and Windkessel arterial compliance (Cwk).
RESULTS: Africans displayed higher suPAR, CRP, PWV and lower Cwk (p<0.001) compared to Caucasians. SuPAR was elevated in Africans irrespective of gender and smoking. We found strong relationships between PWV and suPAR (r=0.27; p<0.001) and Cwk and suPAR (r=-0.39; p<0.001) in the whole group, but found no independent relationship of any arterial stiffness measure and suPAR in Africans after adjustment for confounders. Caucasian men indicated a weak significant independent association between Cwk and suPAR (β=-0.09; p=0.028).
CONCLUSION: Africans had higher levels of suPAR and arterial stiffness than Caucasians (p<0.001), but there was no independent relationship between arterial stiffness and suPAR in the Africans. It is speculated that due to the inflammatory role of suPAR, it will have stronger relationships with atherosclerosis, which has not yet manifested in this relatively young population group. SuPAR may therefore not be an ideal early marker of cardiovascular dysfunction, but may rather indicate established CVD.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22113150     DOI: 10.1016/j.thromres.2011.10.034

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report.

Authors:  Margret E Bock; Heather E Price; Lorenzo Gallon; Craig B Langman
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 8.237

2.  Increased Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in FSGS: A Meta-Analysis.

Authors:  Jiwon M Lee; Jae Won Yang; Andreas Kronbichler; Michael Eisenhut; Gaeun Kim; Keum Hwa Lee; Jae Il Shin
Journal:  J Immunol Res       Date:  2019-04-04       Impact factor: 4.818

3.  Inflammation and salt in young adults: the African-PREDICT study.

Authors:  Simone H Crouch; Shani Botha-Le Roux; Christian Delles; Lesley A Graham; Aletta E Schutte
Journal:  Eur J Nutr       Date:  2020-06-03       Impact factor: 5.614

4.  Inflammation and hypertension development: A longitudinal analysis of the African-PREDICT study.

Authors:  Simone H Crouch; Shani Botha-Le Roux; Christian Delles; Lesley A Graham; Aletta E Schutte
Journal:  Int J Cardiol Hypertens       Date:  2020-12

Review 5.  Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View.

Authors:  Andreas Kronbichler; Moin A Saleem; Björn Meijers; Jae Il Shin
Journal:  J Immunol Res       Date:  2016-07-18       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.